Virginia le Verche

Virginia Le Verche, PhD, serves as the Director of R&D Portfolio & Strategic Initiatives at Rampart Bioscience since May 2022. Virginia co-founded INDuarte Consulting, LLC in January 2019, specializing in strategic and regulatory consulting for cell and gene therapy, with a mission to expedite the development of FDA-approved products. Prior experience includes directing research program coordination at City of Hope, managing preclinical and clinical project initiatives, and serving as a scientist at the SMA Foundation, focusing on therapeutics for Spinal Muscular Atrophy. Virginia's academic background includes research roles at Columbia University Medical Center, with notable contributions to ALS studies, and a Ph.D. from Pierre and Marie Curie University in Cellular and Molecular Neurobiology. Virginia's educational credentials are complemented by certifications in business and management from Columbia University.